touchMEETING HIGHLIGHTS Latest insights on atopic dermatitis and prurigo nodularis
Key updates from 2 cutting-edge expert symposia presented at WCD 2023
The 25th World Congress of Dermatology welcomed healthcare professionals from all over the world to explore the latest scientific research in chronic inflammatory skin diseases.
Dr Koh outlines how younger age at onset of AD is associated with more persistent disease
Dr Tang explains that AD and PN can coexist in some patients. He goes on to outline that AD is associated with substantial patient burden and multiple atopic and non-atopic comorbidities, and that PD presents with distinct comorbidity phenotypes. Lastly, he discusses the key differences in the systemic diseases associated with PN and AD.
Overview & Learning Objectives
Overview
At WCD 2023, the Advent Medical Education Program hosted 2 cutting-edge expert symposia:
- Atopic dermatitis in children: early intervention can reduce long-term disease impact
- Shared and unique roles of IL-4 and IL-13 in atopic dermatitis and prurigo nodularis
Discover more and watch the full symposia at www.adventprogram.com.
Learning Objectives
After watching this activity, participants should be better able to:
- Gain an understanding of the impact of persistent disease in atopic dermatitis from childhood to adulthood
- Explore the relationship between age of onset of atopic dermatitis, increased disease persistence, and the development of other associated atopic conditions
- Understand that atopic dermatitis and prurigo nodularis are two distinct dermatological diseases that can coexist in one patient and are associated with multiple atopic and non-atopic comorbidities
- Differentiate the clinical features of both atopic dermatitis and prurigo nodularis while considering the common and distinct factors that impact their pathophysiology, presentation, and progression
Faculty & Disclosures
Dr Mark Koh
KK Women’s and Children’s Hospital, Singapore
Clinical Associate Professor Mark Koh is a dermatologist, paediatric dermatologist and dermatopathologist. He is head and senior consultant of Dermatology Service, KK Women’s & Children’s Hospital (KKH), as well as visiting consultant at Singapore General Hospital, Sengkang General Hospital and National Cancer Centre.
Dr Mark Koh discloses: Research funding from Abbvie, Amryt, Aslan, Bioderma, FarmaMondo, Galderma, Hyphens, and Lilly; Speaker and/or consulting fees from Abbvie, Bioderma, DKSH, Ego, Galderma, Good Pharma, GSK, Hyphens, LEO, Lion, L’Oreal/LaRoche Posay, Menarini, Novartis, Pfizer, Quoin, Sanofi, and Zuellig.
Dr Mark Tang
The Skin Specialists and Laser Clinic, Mount Alverina Hospital, Singapore
Dr Mark Tang is a fully accredited Consultant Dermatologist with more than 20 years of outstanding clinical practice. He is a well-respected and highly regarded dermatologist and is a key opinion leader in the areas of eczema, immune-mediated skin diseases, wound healing and skin cancers, including skin lymphomas. He is a much sought after invited speaker and faculty member in conferences, workshops advisory boards both locally and overseas. His passion for patient care, research and teaching is evidenced by the numerous patient compliments and many awards he has received throughout his illustrious career.
Dr Mark Tang discloses: Speaker, advisory board member and/or investigator for Bioderma, GSK, Hyphens, LEO Pharma, Menarini, Regeneron, and Sanofi.
